Health Care & Life Sciences » Biotechnology | Pluristem Therapeutics Inc.

Pluristem Therapeutics Inc. | Ownership

Companies that own Pluristem Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
ARK Investment Management LLC
1,436,501
1.3%
669,077
0.06%
06/30/2018
Renaissance Technologies LLC
1,258,500
1.13%
-98,400
0%
06/30/2018
Migdal Mutual Funds Ltd.
256,705
0.23%
-49,139
0.02%
06/28/2018
The California Public Employees Retirement System
181,700
0.16%
0
0%
06/30/2018
UBS Securities LLC
153,622
0.14%
-59,519
0%
06/30/2018
Psagot Mutual Funds Ltd.
126,796
0.11%
929
0.01%
06/30/2018
Geode Capital Management LLC
109,370
0.1%
67,740
0%
06/30/2018
Raymond James & Associates, Inc. (Invt Mgmt)
109,293
0.1%
500
0%
06/30/2018
Lamashkia Mutual Funds Management Co. (1982) Ltd.
99,166
0.09%
36,500
0.14%
05/31/2018
Harel-Pia Mutual Funds Ltd.
96,000
0.09%
32,300
0.01%
06/30/2018

About Pluristem Therapeutics

View Profile
Address
MATAM Advanced Technology Park
Haifa HA 31905
Israel
Employees -
Website http://www.pluristem.com
Updated 07/08/2019
Pluristem Therapeutics, Inc. is a biotechnology company, which engages in the provision of cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The company focuses on cell therapies for the treatment of diseases such as muscle injury, acute radiation syndrome, pulmonary arterial hypertension and others.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.